ABI Reports Earnings Slump, Flat Revenue in Q2 | GenomeWeb

NEW YORK, Jan. 24 - Applied Biosystems reported that fiscal second-quarter earnings contracted amid floundering sales of its gene-research instruments and increased R&D spending.

The company said that net income for the three-month period ended Dec. 31 fell to $49 million, or 23 cents a share, from $58 million, or 26 cents a share, in the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.